- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Candidate Influenza Vaccine GSK1247446A - 2 different formulations
Total 129 results
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedInfluenzaRussian Federation, Germany, France, Greece, United Kingdom, Norway, Estonia
-
GlaxoSmithKlineCompleted
-
Sanofi Pasteur, a Sanofi CompanyActive, not recruitingRespiratory Syncytial Virus ImmunizationUnited States, Australia, Puerto Rico
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedTuberculosisPhilippines
-
GlaxoSmithKlineTerminatedInfluenza | Influenza VaccinesSpain
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedInfluenza | Influenza VaccinesGermany
-
The University of Hong KongCenters for Disease Control and Prevention; Hospital Authority, Hong KongActive, not recruitingInfluenza, HumanChina
-
The University of Hong KongCenters for Disease Control and PreventionActive, not recruiting
-
SanofiCompletedInfluenza | Myxovirus Infection | OrthomyxovirusesUnited States
-
GlaxoSmithKlineCompleted
-
SanofiCompletedInfluenza | Myxovirus InfectionUnited States
-
GlaxoSmithKlineCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
GlaxoSmithKlineCompletedInfluenzaFrance, Spain, Germany, Russian Federation, Estonia, Sweden, Netherlands
-
GlaxoSmithKlineWithdrawn
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
GlaxoSmithKlineCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenzaUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
SanofiCompletedInfluenza | Orthomyxoviridae Infection | Myxovirus InfectionUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
SeqirusCompleted
-
SeqirusCompleted
-
TakedaCompleted
-
ModernaTX, Inc.Active, not recruitingA Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsInfluenza | SARS-CoV-2United States
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
GlaxoSmithKlineCompletedInfections, Papillomavirus | Papillomavirus VaccinesBelgium, United States
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sanofi Pasteur, a Sanofi CompanyTerminatedCOVID-19United States, Australia, Brazil, Honduras
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
GlaxoSmithKlineCompletedInfections, Respiratory Syncytial VirusCanada
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsGermany, Estonia, Belgium, France
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsUnited States, Australia, Germany, Czechia
-
SanofiCompletedPneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal PneumoniaSwitzerland
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineWithdrawnRespiratory Syncytial Virus InfectionsFinland, United States, Spain
-
Novartis VaccinesCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedRespiratory Syncytial Virus InfectionHonduras, United States, Chile
-
Novartis VaccinesCompleted
-
PfizerActive, not recruitingClostridoides Difficile Associated DiseaseUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompletedPneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal PneumoniaSwitzerland